| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1091049151 |
| P356 | DOI | 10.1007/S10620-017-4705-9 |
| P932 | PMC publication ID | 5774232 |
| P698 | PubMed publication ID | 28780607 |
| P50 | author | Linda C O'Dwyer | Q61644102 |
| P2093 | author name string | Itishree Trivedi | |
| Charlesnika T Evans | |||
| Salva N Balbale | |||
| Neil Jordan | |||
| Laurie A Keefer | |||
| Megan C McHugh | |||
| P2860 | cites work | Utilization of the PICO framework to improve searching PubMed for clinical questions | Q21254606 |
| Scoping studies: towards a methodological framework | Q24570441 | ||
| Scoping studies: advancing the methodology | Q24570529 | ||
| Overtreating chronic back pain: time to back off? | Q24649279 | ||
| Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies | Q26749305 | ||
| The potential role of behavioral therapies in the management of centrally mediated abdominal pain | Q26859047 | ||
| Highlights of the 2011 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits | Q28066433 | ||
| Chronic disease management: what will it take to improve care for chronic illness? | Q28144741 | ||
| Narcotic use and misuse in Crohn's disease | Q30459066 | ||
| Usefulness of prescription monitoring programs for surveillance--analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006. | Q33518777 | ||
| A single-question screening test for drug use in primary care | Q33631031 | ||
| Home- versus office-based buprenorphine inductions for opioid-dependent patients | Q33769847 | ||
| Improving chronic illness care: translating evidence into action | Q34111781 | ||
| Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain | Q34118245 | ||
| Project Lazarus: community-based overdose prevention in rural North Carolina | Q34192084 | ||
| Medication reconciliation for controlled substances--an "ideal" prescription-drug monitoring program | Q44336643 | ||
| Rising opioid prescribing in adult U.S. emergency department visits: 2001-2010. | Q44343892 | ||
| Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. | Q44344212 | ||
| Development and validation of a risk score to identify patients at high risk for opioid-related adverse drug events | Q44346760 | ||
| Nonmedical use of opioid analgesics obtained directly from physicians: prevalence and correlates | Q44351161 | ||
| Opioid therapy for chronic pancreatitis: controlling aberrant use through behavioral management | Q44351950 | ||
| Clinical and economic burden of emergency department visits due to gastrointestinal diseases in the United States. | Q44791215 | ||
| The burden of comedication among patients with inflammatory bowel disease | Q44995617 | ||
| A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease | Q45349135 | ||
| Diagnosis, characterization, and 3-month outcome after detoxification of 39 patients with narcotic bowel syndrome. | Q46033333 | ||
| Improving primary care for patients with chronic illness: the chronic care model, Part 2. | Q46071083 | ||
| Predicting Costs of Care for Patients With Inflammatory Bowel Diseases | Q50319887 | ||
| Redesigning delivery of opioids to optimize pain management, improve outcomes, and contain costs. | Q50883250 | ||
| Narcotic use in patients with Crohn's disease. | Q51839450 | ||
| Chronic narcotic use in inflammatory bowel disease patients: prevalence and clinical characteristics. | Q52280881 | ||
| Is narcotic addiction more prevalent in IBD patients? | Q52293523 | ||
| Care plans for patients with frequent ED visits for such chief complaints as back pain, migraine, and abdominal pain | Q79816226 | ||
| Frequency and distribution of multiple diagnoses in chronic pelvic pain related to previous abuse or drug-seeking behavior | Q80496692 | ||
| Differences in healthcare utilization and associated costs between patients prescribed vs. nonprescribed opioids during an inpatient or emergency department visit | Q87015553 | ||
| A challenging crossroad for emergency medicine: the epidemics of pain and pain medication deaths | Q87743763 | ||
| Burden of gastrointestinal disease in the United States: 2012 update | Q34293512 | ||
| The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop | Q34457772 | ||
| CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. | Q34518212 | ||
| Using the chronic care model to improve treatment of alcohol use disorders in primary care settings | Q35114036 | ||
| Opioid bowel dysfunction and narcotic bowel syndrome: a population-based study | Q35532548 | ||
| A Multicomponent Intervention to Improve Primary Care Provider Adherence to Chronic Opioid Therapy Guidelines and Reduce Opioid Misuse: A Cluster Randomized Controlled Trial Protocol | Q35740890 | ||
| Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991-2012. | Q35795201 | ||
| California emergency department visit rates for medical conditions increased while visit rates for injuries fell, 2005-11. | Q35866567 | ||
| The narcotic bowel syndrome: clinical features, pathophysiology, and management | Q36136622 | ||
| Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management | Q36772132 | ||
| Associations between medication use and functional gastrointestinal disorders: a population-based study | Q36780776 | ||
| Using the chronic care model to tackle depression among older adults who have long-term physical conditions | Q36790005 | ||
| Diabetes and the chronic care model: a review | Q37065830 | ||
| Interpreting the National Hospital Ambulatory Medical Care Survey: United States Emergency Department Opioid Prescribing, 2006-2010. | Q37098655 | ||
| A research agenda for enhancing appropriate opioid prescribing in primary care | Q37203669 | ||
| Narcotic use for inflammatory bowel disease and risk factors during hospitalization. | Q37270024 | ||
| Patients as collaborators: using focus groups and feedback sessions to develop an interactive, web-based self-management intervention for chronic pain | Q37325568 | ||
| Clinical features and outcome of patients with inflammatory bowel disease who use narcotics: a case-control study | Q37358178 | ||
| Evidence on the Chronic Care Model in the new millennium | Q37388592 | ||
| Beyond tricyclics: new ideas for treating patients with painful and refractory functional gastrointestinal symptoms | Q37643415 | ||
| Opioid prescribing in emergency departments: the prevalence of potentially inappropriate prescribing and misuse | Q38103154 | ||
| Diagnosis and treatment of narcotic bowel syndrome | Q38206072 | ||
| The use of opioid analgesics for chronic pain: minimizing the risk for harm | Q38248062 | ||
| Pain management in patients with inflammatory bowel disease: translational approaches from bench to bedside | Q38248113 | ||
| Penetrating Disease, Narcotic Use, and Loop Ostomy Are Associated with Ostomy and IBD-related Complications After Ostomy Surgery in Crohn's Disease Patients. | Q38564693 | ||
| Are self-management strategies effective in chronic pain treatment? | Q38672256 | ||
| The prevalence and predictors of opioid use in inflammatory bowel disease: a population-based analysis | Q39136609 | ||
| Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines - United States, 2012. | Q39204538 | ||
| Mindfulness-oriented recovery enhancement reduces pain attentional bias in chronic pain patients | Q39367541 | ||
| Who is prescribing controlled medications to patients who die of prescription drug abuse? | Q40420656 | ||
| Trends in Opioid Analgesic-Prescribing Rates by Specialty, U.S., 2007-2012. | Q41036887 | ||
| Prescription opioid analgesic use among adults: United States, 1999-2012. | Q41352168 | ||
| Screening for current opioid misuse and associated risk factors among patients with chronic nonalcoholic pancreatitis pain | Q41379700 | ||
| President Obama Proposes $1.1 Billion in New Funding to Address the Prescription Opioid Abuse and Heroin Use Epidemic | Q42103303 | ||
| A startling injustice: pain, opioids, and addiction | Q42144354 | ||
| Pain and opioid use in chronic pancreatitis | Q44329903 | ||
| Increasing frequency of opioid prescriptions for chronic abdominal pain in US outpatient clinics | Q44330233 | ||
| A Proactive Response to Prescription Opioid Abuse | Q44335156 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | scoping review | Q101116078 |
| P304 | page(s) | 2668-2685 | |
| P577 | publication date | 2017-08-05 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Strategies to Identify and Reduce Opioid Misuse Among Patients with Gastrointestinal Disorders: A Systematic Scoping Review | |
| P478 | volume | 62 |
Search more.